LOGIN  |  REGISTER

Perimeter Medical Imaging AI (TSX.V: PINK) Stock Quote

Last Trade: C$0.53 0.01 1.92
Volume: 23,350
5-Day Change: -7.02%
YTD Change: -56.56%
Market Cap: C$34.480M

Latest News From Perimeter Medical Imaging AI

TORONTO and DALLAS , Oct. 10, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce the second and final closing (the "Second Closing") of its non-brokered private placement of common shares in the capital of the Company ("Common Shares") announced on September 10, 2024 (the "Offering"). Under the Second... Read More
Perimeter OCT B-Series is the first system designed to combine AI with optical coherence tomography for margin assessment, with the aim of reducing the unacceptably high reoperation rates associated with BCS Recent study 1 published in the Annals of Surgical Oncology revealed reoperation rates of 21.1% among commercially insured women and 14.9% among the Medicare cohort Primary endpoint results from OCT B-Series pivotal... Read More
TORONTO and DALLAS , Sept. 30, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, is pleased to announce the closing of its non-brokered private placement of common shares in the capital of the Company ("Common Shares") announced on September 10, 2024 (the "Offering"). The Company issued 23,470,560 Common Shares at a price... Read More
TORONTO and DALLAS , Sept. 10, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today announced that it is undertaking a non-brokered private placement of up to 32,175,032 common shares in the capital of the Company ("Common Shares") at a price of $0.42 per Common Share, for aggregate gross proceeds of up to approximately... Read More
Conference Call/Webcast Today at 5 pm ET TORONTO and DALLAS , Aug. 14, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company"), a commercial-stage medical technology company, today reported financial results for its second quarter ended June 30, 2024 and provided a corporate update. Business Highlights The Company continues to gain positive commercial market... Read More
TORONTO and DALLAS , Aug. 7, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company"), a commercial-stage medical technology company, announced it will report its second quarter 2024 financial and operating results after market close on Wednesday, August 14, 2024 . Following the announcement, Perimeter management will host a webcast and conference call to discuss the... Read More
TORONTO and DALLAS , June 19, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company, today announced that it will host a webcast investor presentation on Tuesday, June 25, 2024 at 2:00 PM ET . During the webcast, Adrian Mendes , CEO, Andrew Berkeley , CIO and Sara Brien , CFO, will conduct a presentation that will... Read More
Conference Call/Webcast Today at 5 pm ET TORONTO and DALLAS , May 14, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its first quarter ended March 31, 2024 and provided a corporate update. Adrian Mendes , Perimeter's Chief Executive Officer stated, "This past quarter we... Read More
TORONTO and DALLAS , May 9, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced it will report its first quarter 2024 financial and operating results after the close of U.S. financial markets on Tuesday, May 14, 2024 . Following the announcement, Perimeter management will host a webcast and conference... Read More
TORONTO and DALLAS , April 16, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced a newly published webinar, "Trends in Artificial Intelligence (AI) and Innovators in Healthcare" featuring a fireside chat with Anantha Kancherla , former head of Meta's AI platform, and current member of Perimeter's... Read More
TORONTO and DALLAS , April 4, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that it will participate in the upcoming American Society of Breast Surgeons (ASBrS), featuring interactive demos of the S-Series OCT device at the Company's booth. The Company also announced the grant of certain stock... Read More
Conference Call/Webcast Today at 4:30 pm ET TORONTO and DALLAS , March 28, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for the quarter and year ended December 31, 2023 and provided a corporate update. Adrian Mendes , Perimeter's Chief Executive Officer stated, "Reflecting... Read More
DALLAS and TORONTO , March 20, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced upcoming events and provided a corporate update on grant funding opportunities to support its next-generation AI technology development. Adrian Mendes , Perimeter's Chief Executive Officer, stated, "As we continue to ramp... Read More
DALLAS and TORONTO , Feb. 29, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced results from a peer-reviewed retrospective study 1 examining the integration of Wide Field Optical Coherence Tomography (WF-OCT) with Perimeter's proprietary and investigational "ImgAssist" artificial intelligence... Read More
DALLAS and TORONTO , Feb. 20, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced results from a new study 1 published in the Annals of Surgical Oncology that provide a comprehensive and up-to-date understanding of population-level reoperation rates and incremental healthcare costs associated with... Read More
DALLAS and TORONTO , Feb. 7, 2024 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced further commercial expansion within a major national healthcare system, with a follow-on placement of its flagship Perimeter S-Series OCT system at a new hospital site in North Texas . Adrian Mendes , Perimeter's... Read More
DALLAS and TORONTO , Dec. 14, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced a follow-on commercial placement of its flagship Perimeter S-Series OCT system at a new hospital site within one of the largest healthcare networks in North Texas , which is part of a major national healthcare... Read More
DALLAS and TORONTO , Nov. 27, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced that it will participate in an investor webinar hosted by PropThink Conferences featuring Dr. Amelia Tower , breast surgical oncologist, to discuss the re-excision epidemic and potential benefits of AI in cancer... Read More
Company Announces Appointment of Adrian Mendes to Board of Directors Conference Call/Webcast Today at 5 pm ET TORONTO and DALLAS , Nov. 14, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today reported financial results for its third quarter ended September 30, 2023 and provided a corporate update. Quarterly... Read More
Hosting Call on Tuesday, November 14 th at 5 pm ET TORONTO and DALLAS , Nov. 8, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc . (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced it will report its third quarter 2023 financial and operating results after the close of U.S. financial markets on Tuesday, November 14, 2023 . Conference Call/Webcast... Read More
DALLAS and TORONTO , Oct. 31, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced the initiation of an additional clinical trial site at the University of Washington / Fred Hutch Cancer Center located in Seattle, WA. Perimeter is conducting an ongoing multi-center, randomized two-arm pivotal clinical... Read More
DALLAS and TORONTO , Oct. 17, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – today announced that it will host an investor webcast presentation on Wednesday, October 25, 2023 , at 2:00 PM ET to provide an overview of key areas of Perimeter's business. Following prepared remarks, investors will have an... Read More
TORONTO and DALLAS , Sept. 13, 2023 /CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a commercial-stage medical technology company – announced that, on September 13, 2023 , it granted 3,523,408 stock options to certain directors, officers, consultants, and employees of the Company. Each stock option entitles the holder to acquire one common share of the Company... Read More
(TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC) – Perimeter Medical Imaging AI, Inc. (“Perimeter” or the “Company”) – a commercial-stage medical technology company – today reported leadership changes, including the appointment of Suzanne Foster as Chair of its Board of Directors, effective immediately. Jeremy Sobotta, Perimeter’s Chief Executive Officer stated, “Suzanne is a global industry leader with more than 25 years of healthcare... Read More
Completed two follow-on commercial placements of Perimeter S-Series OCT at the end of 2022 Doubled the commercial installed base of S-Series OCT during Q4 2022 Perimeter Medical Imaging AI, Inc. (TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC)(“Perimeter” or the “Company”) – a commercial-stage medical technology company – today reported two new commercial installations of its flagship Perimeter S-Series OCT system, which were completed... Read More
Research concludes WF-OCT allowed for real-time margin visualization of excised oral and oropharyngeal tissue without impacting specimen integrity or surgical and pathology workflows TORONTO & DALLAS--( BUSINESS WIRE )-- Perimeter Medical Imaging AI, Inc. (TSX-V: PINK)(OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) announced the publication of a peer-reviewed research article in JAMA Otolaryngology—Head and Neck... Read More
Astria Therapeutics

COPYRIGHT ©2023 HEALTH STOCKS HUB